Dow Jones Biotechnology Companies By Shares Outstanding

LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Shares Outstanding
Return On Equity
Return On Asset
Profit Margin
Operating Margin
Current Valuation
Shares Outstanding
Shares Owned By Insiders
Shares Owned By Institutions
Number Of Shares Shorted
Price To Earning
Price To Book
Price To Sales
Revenue
Gross Profit
EBITDA
Net Income
Cash And Equivalents
Cash Per Share
Total Debt
Debt To Equity
Current Ratio
Book Value Per Share
Cash Flow From Operations
Short Ratio
Earnings Per Share
Price To Earnings To Growth
Target Price
Number Of Employees
Beta
Market Capitalization
Total Asset
Retained Earnings
Working Capital
Current Asset
Current Liabilities
Shares OutstandingEfficiencyMarket RiskExp Return
1ABBV AbbVie Inc
1.77 B
 0.20 
 1.38 
 0.27 
2GILD Gilead Sciences
1.25 B
 0.22 
 1.55 
 0.34 
3OPK Opko Health
671.55 M
 0.10 
 2.57 
 0.27 
4AMGN Amgen Inc
537.2 M
 0.20 
 1.49 
 0.30 
5MNKD MannKind Corp
275.78 M
(0.22)
 1.85 
(0.40)
6VRTX Vertex Pharmaceuticals
256.79 M
 0.24 
 1.48 
 0.35 
7INCY Incyte
193.52 M
(0.08)
 2.18 
(0.17)
8BMRN Biomarin Pharmaceutical
190.78 M
 0.09 
 1.63 
 0.15 
9ACAD ACADIA Pharmaceuticals
166.79 M
 0.03 
 2.78 
 0.07 
10ALKS Alkermes Plc
162.61 M
 0.13 
 1.88 
 0.25 
11NVAX Novavax
160.84 M
(0.02)
 4.65 
(0.10)
12IONS Ionis Pharmaceuticals
158.96 M
(0.06)
 2.60 
(0.15)
13ILMN Illumina
158.4 M
(0.29)
 2.72 
(0.79)
14TECH Bio Techne Corp
158.09 M
(0.14)
 2.16 
(0.31)
15BIIB Biogen Inc
146.38 M
(0.07)
 1.73 
(0.12)
16ALNY Alnylam Pharmaceuticals
129.43 M
 0.08 
 3.00 
 0.25 
17HALO Halozyme Therapeutics
123.53 M
 0.33 
 1.45 
 0.47 
18REGN Regeneron Pharmaceuticals
107.51 M
(0.07)
 2.04 
(0.13)
19NBIX Neurocrine Biosciences
99.7 M
(0.10)
 2.80 
(0.27)
20RARE Ultragenyx
92.5 M
(0.06)
 2.44 
(0.15)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds. Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY